曲妥珠单抗
生物仿制药
医学
肿瘤科
内科学
养生
乳腺癌
临床试验
帕妥珠单抗
不利影响
化疗
队列
转移性乳腺癌
新辅助治疗
作者
Mingyu Wang,Xingye Sheng,Qiannan Zhu,Danni Shen,Junhan Li,Xincheng Tao,Jue Wang,Xiaoming Zha
标识
DOI:10.1080/14712598.2026.2649512
摘要
HLX02 demonstrated equivalent efficacy and safety to the originator trastuzumab in this setting, representing a cost-effective treatment alternative.
科研通智能强力驱动
Strongly Powered by AbleSci AI